Is a complete STIM research report available?

No complete published report is available for Neuronetics, Inc. (STIM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Neuronetics, Inc. (STIM)

NASDAQ: STIM · USD

$2.27

+0.08 (+3.6%)· Recorded snapshot

Market cap	173M
Revenue (ttm)	155.1M
Net income (ttm)	-30.4M
EPS (ttm)	-$0.44
Shares out	76.2M
Volume	288,231
Beta	1.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 155.1M
Net income (ttm): -30.4M
EPS (ttm): -$0.44
Market cap: 173M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001227636
Company name	Neuronetics, Inc.
Country	United States
Country code	US
CUSIP number	64131A105
Earnings date	2026-11-04
Earnings time	bmo
Employees	658
Employees change	-58
Employees growth	-8.1%
Enterprise value	$240.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
Industry	Medical Devices
IPO date	2018-06-28
Is primary listing	Yes
Is SPAC	No
ISIN number	US64131A1051
Last 10-K release date	2026-03-17
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$173M
Market cap category	Micro-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$2.27
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	STIM
U.S. state	Pennsylvania
Website	https://neurostar.com/neuronetics

Metric

Value

Amount currency

USD

CIK code

0001227636

Company name

Neuronetics, Inc.

Country

United States

Country code

CUSIP number

64131A105

Earnings date

2026-11-04

Earnings time

bmo

Employees

658

Employees change

-58

Employees growth

-8.1%

Enterprise value

$240.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2003

Industry

Medical Devices

IPO date

2018-06-28

Is primary listing

Yes

Is SPAC

ISIN number

US64131A1051

Last 10-K release date

2026-03-17

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$173M

Market cap category

Micro-Cap

Next earnings date

2026-11-04

Options

Yes

Price

$2.27

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

STIM

U.S. state

Pennsylvania

Website

https://neurostar.com/neuronetics

Metric	Value
Earnings yield	-19.23%
EV/Sales	1.55x
FCF / EV yield	-4.69%
FCF yield	-6.52%
Forward EV/Sales	1.42x
Forward P/S	1.02x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	9.35x
P/S ratio	1.11x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-19.23%

EV/Sales

1.55x

FCF / EV yield

-4.69%

FCF yield

-6.52%

Forward EV/Sales

1.42x

Forward P/S

1.02x

Industry forward P/E

19.74x

Industry P/E

39.16x

P/B ratio

9.35x

P/S ratio

1.11x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-14.48%
EBITDA margin	-12.42%
Gross margin	49.38%
Operating margin	-14.48%
Pretax margin	-19.89%
Profit margin	-19.62%
Profit per employee	$-46,249
Revenue per employee	$235,708
ROA	-10.55%
ROA (5Y)	-15.67%
ROCE	-21.76%
ROE	-116.1%
ROE (5Y)	-88.44%
ROIC	-12.74%
SBC / revenue	3.84%

Metric

Value

EBIT margin

-14.48%

EBITDA margin

-12.42%

Gross margin

49.38%

Operating margin

-14.48%

Pretax margin

-19.89%

Profit margin

-19.62%

Profit per employee

$-46,249

Revenue per employee

$235,708

ROA

-10.55%

ROA (5Y)

-15.67%

ROCE

-21.76%

ROE

-116.1%

ROE (5Y)

-88.44%

ROIC

-12.74%

SBC / revenue

3.84%

Metric	Value
EPS growth quarters	6
EPS growth years	1
Gross profit growth	21.59%
Gross profit growth (Q)	19.51%
Gross profit growth 3Y	14.59%
Gross profit growth 5Y	12.17%
Net income growth quarters	4
Net income growth years	1
Revenue growth	39.59%
Revenue growth (Q)	9.08%
Revenue growth (QoQ)	20.65%
Revenue growth 3Y	31.73%
Revenue growth 5Y	23.26%
Revenue growth quarters	8
Revenue growth years	5

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

21.59%

Gross profit growth (Q)

19.51%

Gross profit growth 3Y

14.59%

Gross profit growth 5Y

12.17%

Net income growth quarters

Net income growth years

Revenue growth

39.59%

Revenue growth (Q)

9.08%

Revenue growth (QoQ)

20.65%

Revenue growth 3Y

31.73%

Revenue growth 5Y

23.26%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-944,000
Depreciation and amortization	$3.2M
EBIT	$-22.5M
EBITDA	$-19.3M
EPS	$-0.44
FCF per share	$-0.15
Financing cash flow	$18.7M
Free cash flow	$-11.3M
Free cash flow minus SBC	$-17.2M
Gross profit	$76.6M
Investing cash flow	$-919,000
Net borrowing	$4.8M
Net cash flow	$7.5M
Net income	$-30.4M
Operating cash flow minus SBC	$-16.3M
Operating income	$-22.5M
Revenue	$155.1M
Stock-based compensation	$6M

Metric

Value

Capital expenditures

$-944,000

Depreciation and amortization

$3.2M

EBIT

$-22.5M

EBITDA

$-19.3M

EPS

$-0.44

FCF per share

$-0.15

Financing cash flow

$18.7M

Free cash flow

$-11.3M

Free cash flow minus SBC

$-17.2M

Gross profit

$76.6M

Investing cash flow

$-919,000

Net borrowing

$4.8M

Net cash flow

$7.5M

Net income

$-30.4M

Operating cash flow minus SBC

$-16.3M

Operating income

$-22.5M

Revenue

$155.1M

Stock-based compensation

$6M

Metric	Value
Altman Z-Score	-3.39
Book value per share	$0.23
Debt / equity	4
Goodwill	$23.6M
Interest coverage	-2.52
Long-term assets	$78.3M
Long-term liabilities	$81.6M
Net cash (debt)	$-67.3M
Net cash / market cap	-39.01%
Net debt / equity	3.11
Piotroski F-Score	2
Property, plant and equipment	$27.4M
Shareholders' equity	$21.6M
Tangible book value	$-24.7M
Tangible book value per share	$-0.32
Total assets	$131.5M
Total cash	$19.2M
Total debt	$86.5M
Total liabilities	$109.9M
WACC	9.94%

Metric

Value

Altman Z-Score

-3.39

Book value per share

$0.23

Debt / equity

Goodwill

$23.6M

Interest coverage

-2.52

Long-term assets

$78.3M

Long-term liabilities

$81.6M

Net cash (debt)

$-67.3M

Net cash / market cap

-39.01%

Net debt / equity

3.11

Piotroski F-Score

Property, plant and equipment

$27.4M

Shareholders' equity

$21.6M

Tangible book value

$-24.7M

Tangible book value per share

$-0.32

Total assets

$131.5M

Total cash

$19.2M

Total debt

$86.5M

Total liabilities

$109.9M

WACC

9.94%

Metric	Value
Asset turnover	1.17
Current assets	$53.2M
Current liabilities	$28.3M
Current ratio	1.88
Inventory turnover	15.03
Net working capital	$10.9M
Quick ratio	1.25
Working capital	$24.9M
Working capital turnover	5.82

Metric

Value

Asset turnover

1.17

Current assets

$53.2M

Current liabilities

$28.3M

Current ratio

1.88

Inventory turnover

15.03

Net working capital

$10.9M

Quick ratio

1.25

Working capital

$24.9M

Working capital turnover

5.82

Metric	Value
Buyback yield / dilution	-42.95%
Dividend yield	0%
Shareholder yield	-42.95%

Metric

Value

Buyback yield / dilution

-42.95%

Dividend yield

Shareholder yield

-42.95%

Metric	Value
150-day SMA	$1.96
1D price change	3.65%
1M price change	-17.34%
1M total return	-17.34%
1W price change	14.39%
1W total return	14.39%
1Y price change	-26.7%
1Y return CAGR	-26.71%
1Y total return	-26.7%
20-day SMA	$2.09
200-day SMA	$1.87
3M price change	25.14%
3M total return	25.14%
3Y price change	115.71%
3Y return CAGR	29.2%
3Y total return	115.71%
50-day SMA	$2.55
50-day SMA vs 200-day SMA	50over200
52-week high	$3.44
52-week high date	2026-08-12
52-week low	$0.80
52-week low date	2026-03-17
5Y price change	-55.93%
5Y return CAGR	-15.12%
5Y total return	-55.93%
6M price change	34.02%
6M total return	34.02%
All-time high	$39.39
All-time high date	2018-09-07
All-time low	$0.52
All-time low date	2024-11-12
Average true range (ATR)	$0.14
Average volume	697.8K
Beta (1Y)	3.16
Beta (2Y)	2.05
Beta (5Y)	1.2
Change from 52-week high	-34.01%
Change from 52-week low	183.75%
Change from all-time high	-94.25%
Change from all-time low	335.58%
Change from open	3.89%
Day's gap	-0.23%
Dollar volume	$654,284
High price	$2.27
Low price	$2.19
Monthly RSI	48.88
Open price	$2.19
Position in 52-week range	100%
Premarket change	0.46%
Premarket close	$2.19
Premarket price	$2.20
Premarket volume	504
Previous close	$2.19
Price vs 150-day SMA	15.38%
Price vs 20-day SMA	8.22%
Price vs 200-day SMA	21.32%
Price vs 50-day SMA	-11.32%
Relative volume	0.41
RSI	51.45
Sharpe ratio	0.24
Sharpe ratio (3Y)	0.77
Sharpe ratio (5Y)	0.27
Sortino ratio	0.46
Sortino ratio (3Y)	1.25
Sortino ratio (5Y)	0.48
Volume	288.2K
Weekly RSI	51.29
YTD price change	64.13%
YTD total return	64.13%

Metric

Value

150-day SMA

$1.96

1D price change

3.65%

1M price change

-17.34%

1M total return

-17.34%

1W price change

14.39%

1W total return

14.39%

1Y price change

-26.7%

1Y return CAGR

-26.71%

1Y total return

-26.7%

20-day SMA

$2.09

200-day SMA

$1.87

3M price change

25.14%

3M total return

25.14%

3Y price change

115.71%

3Y return CAGR

29.2%

3Y total return

115.71%

50-day SMA

$2.55

50-day SMA vs 200-day SMA

50over200

52-week high

$3.44

52-week high date

2026-08-12

52-week low

$0.80

52-week low date

2026-03-17

5Y price change

-55.93%

5Y return CAGR

-15.12%

5Y total return

-55.93%

6M price change

34.02%

6M total return

34.02%

All-time high

$39.39

All-time high date

2018-09-07

All-time low

$0.52

All-time low date

2024-11-12

Average true range (ATR)

$0.14

Average volume

697.8K

Beta (1Y)

3.16

Beta (2Y)

2.05

Beta (5Y)

1.2

Change from 52-week high

-34.01%

Change from 52-week low

183.75%

Change from all-time high

-94.25%

Change from all-time low

335.58%

Change from open

3.89%

Day's gap

-0.23%

Dollar volume

$654,284

High price

$2.27

Low price

$2.19

Monthly RSI

48.88

Open price

$2.19

Position in 52-week range

100%

Premarket change

0.46%

Premarket close

$2.19

Premarket price

$2.20

Premarket volume

504

Previous close

$2.19

Price vs 150-day SMA

15.38%

Price vs 20-day SMA

8.22%

Price vs 200-day SMA

21.32%

Price vs 50-day SMA

-11.32%

Relative volume

0.41

RSI

51.45

Sharpe ratio

0.24

Sharpe ratio (3Y)

0.77

Sharpe ratio (5Y)

0.27

Sortino ratio

0.46

Sortino ratio (3Y)

1.25

Sortino ratio (5Y)

0.48

Volume

288.2K

Weekly RSI

51.29

YTD price change

64.13%

YTD total return

64.13%

Metric	Value
Float	37.2M
Float percentage	48.76%
Shares change (QoQ)	5.09%
Shares change (YoY)	42.95%
Shares held by insiders	19.88%
Shares held by institutions	24.66%
Shares outstanding	76.2M
Short % of float	19.02%
Short % of shares	9.28%
Short ratio	5.6 days

Metric

Value

Float

37.2M

Float percentage

48.76%

Shares change (QoQ)

5.09%

Shares change (YoY)

42.95%

Shares held by insiders

19.88%

Shares held by institutions

24.66%

Shares outstanding

76.2M

Short % of float

19.02%

Short % of shares

9.28%

Short ratio

5.6 days

Neuronetics, Inc. (STIM)

Price

Financial snapshot

Fair-value bridge

Latest news · STIM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All STIM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on STIM

Frequently asked questions